[18F]AlF-FAPI-74

N/A

Report date: 2025/09/09 13:36:20

NME

Base Information

Drug Name[18F]AlF-FAPI-74

Drug Alias Name18F-AlF-FAPI-74[18F]-ALF-FAPI-74

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionFibroblast activation protein alpha modulators

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesUmc Utrecht

China Registration ClassN/A

Develop Information

Active CompaniesUmc Utrecht

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A